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The study of isolated primary progenitor cells offers great insight into developmental 
biology and human disease.  In particular, ex vivo culture of isolated primary erythroid 
progenitor cells replicates the differentiation events that occur during in vivo 
erythropoiesis.  Here we report a high-efficiency method for CRISPR-Cas9 mediated 
gene disruption in isolated primary erythroid progenitor cells.  We use this method to 
generate the novel result that Lmna is required in terminal erythroid differentiation. 
 
Terminal erythroid differentiation is initiated by binding of Erythropoietin (Epo) to Epo 
receptors on the surface of CFU-E erythroid progenitors, leading to 3 to 6 terminal 
divisions, induction of ~600 genes, and repression of thousands of others in a defined 
temporal order. Concomitantly there are major changes in cytoskeletal and nuclear 
architecture, including condensation of the nucleus to about one-tenth its original volume 
and, only in mammals, enucleation.1,2,3  Numerous human diseases cause disordered 
erythropoiesis and result in significant morbidity and mortality.  In many cases the 
underlying mechanisms of disease are incompletely understood, and more importantly, 
identification of disease modifier genes and their function in terminal erythropoiesis is 
incomplete.4   
 
Ex vivo culture and differentiation of isolated primary mouse erythroid progenitor cells 
faithfully mimics the cellular events that occur during in vivo erythropoiesis, including 
proliferation, upregulation of erythroid-specific genes and cell surface markers, 
accumulation of hemoglobin, and enucleation.5  RNA interference has been used for the 
study of gene function in erythropoiesis, but the use of small hairpin RNAs is complicated 
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by difficulty in predicting efficiency of gene knockdown and non-specific effects.6  Several 
genetic determinants of erythropoiesis have been assessed using erythroid progenitors 
isolated from gene knock-out mice,7,8 but this is a laborious process involving de novo 
generation of individual mouse lines that is not amenable to high-throughput assessment 
of candidate genes.   
 
CRISPR-Cas9 technology has allowed rapid genetic loss of function in many organisms 
via nuclease-mediated gene disruption.9,10  Intracellular delivery of the prokaryotic Cas9 
nuclease complexed with a single-guide RNA (sgRNA) molecule results in sgRNA-
directed cleavage of a specific genomic site by Cas9.  The DNA double strand break 
induced by Cas9 cleavage is then frequently repaired by the endogenous non-
homologous end joining (NHEJ) DNA repair pathway, resulting in insertion and deletion 
(indel) mutations that disrupt gene expression.9,10   
 
However, successful use of CRISPR-Cas9 in isolated primary erythroid cells has not yet 
been described.  Here we report a highly efficient method for delivering the 
Streptococcus pyogenes Cas9 protein and an sgRNA to isolated primary erythroid 
progenitor cells.  Cas9 and sgRNA delivery with this method results in robust genetic 
loss of function through gene disruption, and we use this method to identify a novel gene 
required in terminal erythropoiesis.  
 
To deliver Cas9 and an sgRNA to primary erythroid progenitor cells, we constructed a 
murine stem cell virus (MSCV)-based retroviral vector co-expressing Cas9 and green 
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fluorescent protein (GFP) linked by a self-cleaving 2A peptide to mediate equimolar 
expression of Cas9 and GFP from a single Pol II promoter cassette.  This vector also 
expresses an sgRNA from a Pol III promoter cassette (Figure 1A).  Using this vector we 
transduced primary lineage negative erythroid progenitor cells purified from E14.5 mouse 
fetal livers, and cultured them in an erythroid progenitor expansion media containing 
cytokines that promote proliferation but not differentiation. GFP positive cells were 
isolated by fluorescence activated cell sorting (FACS) between 24 to 72 hours post-
transduction depending on the desired degree of cell expansion (Figure 1B).  
Importantly, our retroviral vector delivering Cas9 and sgRNA was capable of high 
efficiency transduction such that the majority of the progenitor cell population was 
successfully transduced (Figure 1C). GFP positive cells were then placed in erythroid 
differentiation medium for 48 hours (Figure 1B).   
 
To assay gene disruption efficiency we co-delivered Cas9 with three different sgRNAs 
(Supplemental Table S1), one targeting the start codon of the Gata3 gene, which 
encodes a T-lymphocyte specific transcription factor, one targeting the 5’ end of the Lcp2 
gene, which encodes a signal-transduction adaptor protein, and one targeting the start 
codon of the Bcl11a gene, which encodes a multi-lineage transcription factor that is 
expressed in erythroid precursor cells.  For all 3 vectors, transduction efficiency was 
greater than 50% when performing FACS for GFP positive cells (data not shown).  Using 
the Surveyor nuclease assay on GFP positive cells, we detected robust generation of 
indels in each of these genes (Figures 1D-F). 
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As the Surveyor nuclease assay suggested the presence of a mixed population of bi-
allelically disrupted, haploinsufficient, and wild-type cells, we sought to assess if the 
observed gene disruption rates resulted in loss of protein expression and an observable 
phenotype.  To determine if gene disruption through indel generation resulted in loss of 
protein expression, we assessed levels of the protein encoded by the Bcl11a gene and 
found nearly 80% decreased expression in cells transduced with vector expressing Cas9 
and an sgRNA targeting Bcl11a (Figure 1G), indicating the percent indels reflected by 
the Surveyor assay only provided a minimum estimate of gene inactivation.  As Bcl11a 
controls the developmental switch to adult hemoglobin in mammalian erythropoiesis and 
mouse models genetically deficient in Bcl11a have elevations in εγ globin gene 
expression,7 we determined whether primary erythroid progenitors had elevations in εγ 
globin gene expression following disruption of the Bcl11a gene.  In reticulocytes 
differentiated from progenitor cells transduced with vector expressing Cas9 and an 
sgRNA targeting Bcl11a, there was a greater than fifty-fold increase in εγ globin mRNA, 
replicating the phenotype observed in mice genetically deficient in Bcl11a (Figure 1H). 
 
We next used this system to identify a novel regulator of terminal erythroid differentiation. 
As prior studies of erythropoiesis had not placed significant emphasis on structural 
proteins, we analyzed expression data for all genes encoding such types of proteins. 
Lmna, the gene encoding the alternatively spliced nuclear envelope proteins Lamins A 
and C, exhibited the greatest increase in expression during terminal erythroid 
differentiation, with a 4 to 6-fold increase in relative expression quantified by RNA-seq 
methods.2  This was in contrast to Lamin B, a protein that complexes with Lamins A and 
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C to support nuclear membrane architecture and control transcriptional regulation, but is 
downregulated during terminal erythroid differentiation.3,11,12  Interestingly, Lamin A 
protein exhibited a marked initial increase during terminal differentiation followed by a 
marked decrease (Figures 2A, 2B), whereas Lamin C protein levels were not as dynamic 
(Supplemental Figure S2). 
 
We designed an sgRNA targeting the start codon of Lmna (Supplemental Figure S1).  
Retroviral vector transduction resulted in successful delivery of Cas9 and the Lmna 
sgRNA to greater than 50% of isolated primary erythroid progenitors, as assessed by 
frequency of GFP positive cells when performing FACS (data not shown).  Delivery of 
Cas9 and the sgRNA targeting Lmna to primary erythroid progenitors resulted in efficient 
introduction of indels in the Lmna gene (Figure 2C), and in reduction of Lamins A (Figure 
2D) and C (Supplemental Figure S2) protein levels. Progenitors with a disrupted Lmna 
gene showed impaired proliferation (Figure 2E) as well as a decreased ability to 
accumulate hemoglobin (Figure 2F).  Many cells underwent apoptosis (data not shown).  
There was no difference in upregulation of cell surface markers CD71 and Ter119 
(Supplemental Figure S3), which are relatively earlier events during terminal erythroid 
differentiation.1 These results are the first demonstration that expression of Lmna is 
dynamically regulated during erythropoiesis and that it plays a significant role in terminal 
red cell differentiation.  Although an anemia phenotype has not been reported for Lmna -
/- mice, they do have decreased growth by 3 weeks and die by 8 weeks of life;13 it will be 
interesting to determine whether young Lmna -/- mice do exhibit an anemia phenotype 
under both normal and stress erythropoiesis conditions.14 Further biochemical analyses 
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will be instrumental in determining the underlying mechanism by which Lmna regulates 
terminal erythroid differentiation. 
 
The method we developed for using CRISPR-Cas9 to study genetic loss of function in 
isolated primary erythroid progenitor cells provides a broadly generalizable, rapid, and 
facile assessment of gene function in red blood cell development, with a total duration of 
3 to 5 days from progenitor cell isolation to phenotypic assessment.  Although off-target 
effects of the CRISPR-Cas9 system are of concern, high-throughput sequencing or array 
CGH methods can be used to identify off-target cleavage events, and rescue 
experiments using cDNAs of targeted genes where codons have been substituted to 
ablate sgRNA binding without changing the amino acid sequence can confirm whether 
the observed phenotype is due to on-target or off-target gene disruption.  Additionally, 
the use of novel Cas9 variants with high specificity will mitigate many of these 
concerns.15  Our system has significant strengths in the high transduction rate of our viral 
vector co-expressing Cas9 and an sgRNA, and the high efficiency with which gene 
disruption can be achieved, both of which are key considerations when studying rare and 
difficult-to-isolate cell populations such as hematopoietic progenitors.  Indeed, the ability 
to achieve high-efficiency gene disruption using this system allows the possibility of 
robust large-scale genetic loss-of-function screening in erythropoiesis. 
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Figure Legends 
 
Figure 1 – CRISPR-Cas9 expression in primary fetal liver erythroid progenitors 
mediates disruption of multiple genes and loss of Bcl11a gene function. 
(A).  Diagram of MSCV-based retroviral vector co-delivering Cas9-GFP and sgRNA.  
(B) Schematic of experimental procedure including cytokines used in different culture 
phases. 
(C) Flow cytometry assessment of efficiency of Cas9 and sgRNA delivery to fetal liver 
erythroid progenitor cells as quantified by GFP expression.   
(D-F)  Surveyor nuclease assay of gene disruption efficiency in fetal liver erythroid 
progenitor cells in the Gata3, Bcl11a, and Lcp2 genes following delivery of Cas9 with 
indicated sgRNAs or of Cas9 alone.  Arrows denote cleavage products and lanes without 
indel quantification indicate less than 1% disruption efficiency.   
(G) Western blot assessing level of BCL11A protein and FLAG-tagged Cas9 in fetal liver 
erythroid progenitor cells following delivery of Cas9 with and without sgRNA targeting 
Bcl11a.  Relative expression differences of BCL11A protein quantified by densitometry. 
(H) RT-PCR quantification of relative εγ globin mRNA levels in reticulocytes following 
delivery of Cas9 with Bcl11a sgRNA or Cas9 alone.  Data are represented as mean of 3 
biological replicates and error bars denote standard deviation.  P-value calculated using 
Student’s T-test. 
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Figure 2 – Dynamic regulation of Lamin A during erythroid differentiation and 
impaired terminal erythroid differentiation following CRISPR-Cas9-mediated Lmna 
disruption. 
(A) Western blot of Lamin A protein levels following transition of fetal liver erythroid 
progenitors to differentiation culture.  One million cells were loaded per lane.   
(B) Densitometry quantification of relative changes in Lamin A protein levels following 
transition of fetal liver erythroid progenitors to differentiation culture.  Each data point 
represents the mean of 3 biological replicates with error bars denoting standard 
deviation.  
(C) Surveyor nuclease assay of disruption efficiency of the Lmna gene in fetal liver 
erythroid progenitor cells following delivery of Cas9 with indicated sgRNAs or Cas9 
alone.  Arrows denote cleavage products and lanes without indel quantification indicate 
less than 1% disruption efficiency.   
(D) Western blot assessing levels of Lamin A protein in fetal liver erythroid progenitor 
cells following delivery of empty vector, or Cas9 with, and without an sgRNA targeting 
Lmna.   
(E) Proliferation of fetal liver erythroid progenitors in differentiation medium following 
delivery of empty vector, or Cas9 with and without Lmna sgRNA.  Data points represent 
mean of 3 biological replicates and error bars denote standard deviation.  P-values 
comparing Cas9 with Lmna sgRNA to other conditions calculated using Student’s T-test. 
(F) Hemoglobin content per reticulocyte generated from fetal liver erythroid progenitors 
following delivery of empty vector, or Cas9 with and without sgRNA targeting Lmna.  
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Data represent the mean of 3 biological replicates and error bars denote standard 
deviation.  P-value calculated using Student’s T-test. 
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Supplemental Methods 
 
Plasmids 
The SpCas9 cDNA was PCR amplified from plasmid pX33016 (a kind gift of Dr. 
Feng Zhang, Broad Institute) using Phusion polymerase (New England Biolabs) 
and cloned into the pXZ201 MSCV retroviral vector plasmid17 using EcoRI (New 
England Biolabs) and XhoI (New England Biolabs) restriction sites.  The 2A-GFP 
cDNA was PCR amplified from pXZ201 using Phusion polymerase and an 
extended primer encoding the 2A cDNA and cloned in 3’ to the SpCas9 cDNA 
using a SalI (New England Biolabs) restriction site.  The self-cleaving 2A peptide 
sequence was constructed as previously described.18  The U6 promoter, BbsI 
restriction site, sgRNA construct was PCR amplified from plasmid pX330 using 
Phusion polymerase and cloned in reverse orientation 3’ to the GFP cDNA using 
a NotI (New England Biolabs) restriction site.  Specific guide RNAs were 
synthesized as complimentary oligos (Integrated DNA Technologies), 
phosphorylated with T4 polynucleotide kinase (New England Biolabs), annealed, 
and cloned into the BbsI (New England Biolabs) site. 
 
Retrovirus production 
The 293T cells used for transfection were split and plated at 6 million cells per 10 
cm plate on day -1 in antibiotic - free Dulbecco's Modified Eagle Medium (DMEM) 
with added 15% Fetal Bovine Serum (FBS) and 2 mM L-Glutamine (Invitrogen). 
On day 0, 10 ug plasmids were transfected into 293T cells together with 5 µg 
packaging vector (pCL-Eco, IMGENEX) using Fugene 6 (Promega). Six hours 
later, the culture medium was replaced with DMEM with added 15% FBS, 2 mM 
L-Glutamine and 1× Pen Strep (Invitrogen). On day 1, fresh virus - containing 
supernatant was collected, filtered through 0.45 µm filter (Millipore), and used 
immediately to infect the murine lineage negative fetal liver cells.   
 
Isolation of erythroid progenitors from murine E14.5 fetal liver cells 
Day 14.5 pregnant C57BL/6J mice were anesthetized by carbon dioxide. The 
embryos were isolated and the entire fetal livers were carefully collected in 
Phosphate Buffered Saline (PBS) with 2% Fetal Bovine Serum (FBS) and 100 
µM EDTA. After suspension by pipette tips and filtration through a 70 µm filter 
(BD), the fetal liver cells were incubated with Ammonium Chloride Solution 
(Stemcell) for lysis of red blood cells. Ten minutes later, the remaining fetal liver 
cells were centrifuged at 300x(g) for 5 minutes, and resuspended in PBS. 
Following the manufacturer’s protocol, lineage negative cells were obtained after 
depletion of lineage positive cells magnetically using BD Biotin Mouse Lineage 
Panel (559971) and BD Streptavidin Particles Plus – DM (557812). The detail 
protocol was described previously.5  One fetal liver resulted in the isolation of 
500,000 lineage-negative progenitor cells. 
 
Viral infection and culture of erythroid progenitors 
After isolation, lineage negative fetal liver cells were plated in 24-well plates with 
100,000 cells per well, covered by 1 ml virus containing supernatant, and 
centrifuged at 400x(g) for 90 min at 37°C. After spin-infection, we replaced the 
virus supernatant with erythroid maintenance medium (StemSpan-SFEM 
(StemCell Technologies) with added recombinant mouse stem cell factor (100 
ng/ml SCF, R&D), recombinant mouse IGF-1 (40 ng/ml, R&D), dexamethasone 
(100 nM, Sigma) and erythropoietin (2 u/ml, Amgen)). The cells were cultured 
overnight or for up to three days for recovery and expression of transgenes. Then 
infected cells were pooled and sorted for green fluorescence by FACS sorting at 
flow rate 2. The GFP+ cells were cultured in Epo-only erythroid differentiation 
medium (Iscove modified Dulbecco's medium (IMDM) containing 15% FBS 
(Stemcell), 1% detoxified bovine serum albumin (BSA) (Stemcell), 500 µg/mL 
holo-transferrin (Sigma-Aldrich), 0.5 U/mL Epo (Amgen), 10 µg/mL recombinant 
human insulin (Sigma-Aldrich), 2 mM L-glutamine (Invitrogen) and 1× Pen Strep 
(Invitrogen)).   
 
Flow cytometry (FACS) sorting and analysis 
The cells were pooled, washed once in PBS and resuspended at density of 5-10 
million/ml in PBS with 1 µg/ml PI for FACS sorting or analysis.  Ter119 staining 
was performed using APC Rat Anti-Mouse TER-119 (BD Biosciences) and CD71 
staining was performed using PE Rat Anti-Mouse CD71 (BD Biosciences) as per 
manufacturer’s instructions.  FACS was performed using an ARIA-II sorter 
(Becton-Dickinson) and flow cytometry was performed using a Fortessa flow 
cytometer (Becton-Dickinson). 
 
Protein isolation and Western blotting 
One million cells after 48 hours of differentiation were pelleted, resuspended in 
RIPA lysis buffer (50 mM Tris-HCl at pH 7.4, 150 mM NaCl, 0.1% SDS, 1% NP-
40, 0.25% sodium deoxycholate), and incubated for 30 min on ice. After 
centrifugation at 14,000 rpm in an Eppendorf table-top centrifuge for 5 min at 4°C 
to remove debris, the supernatant was transferred to a new tube, mixed with 
sample loading buffer (Invitrogen), and incubated for 10 min at 90°C. The 
NuPAGE Bis-Tris gel system (Invitrogen) was used to separate proteins, which 
subsequently were transferred to a nitrocellulose membrane using NuPAGE 
transfer buffer (Invitrogen). Membranes were blocked with 3% BSA-PBST for 1 h 
and probed with primary antibody (anti-BCL11A(CTIP1) from Abcam, anti-FLAG 
from Sigma, anti-Lamin A/C from cell signaling technology, anti-Lamin B from 
Santa Cruz, anti-alpha globin from Santa Cruz, and anti-GAPDH from Abcam) at 
1:1,000 dilution in 3% BSA-PBST overnight at 4°C. Membranes were washed 
three times with PBST, incubated with corresponding peroxidase-coupled 
secondary antibodies at a 1:10000 dilution in 3% BSA-PBST for 1 h at room 
temperature, washed twice with PBST, and incubated for 1 min with Western 
Lightning Plus-ECL substrate (Perkin Elmer). Proteins were visualized by 
exposure to scientific imaging film (Kodak).  Densitometry was calculated using 
the ImageJ (freely available from NIH) program. 
 
RNA isolation and real-time PCR 
RNA from 500,000 cells after 48 hours of differentiation was isolated using Trizol 
and purified using RNeasy columns (Qiagen).  Real-time PCR was performed 
using a 7900HT RT-PCR machine (Applied Biosystems) and SYBR green 2X 
PCR master mix (Applied Biosciences).  Mouse epsilon-gamma transcripts were 
amplified using primers Exon1 For- TGGCCTGTGGAGTAAGGTCAA, and Exon2 
Rev- GAAGCAGAGGACAAGTTCCCA, and normalized using the delta-delta Ct 
method to GAPDH transcripts amplified using primers For- 
AGGTTGTCTCCTGCGACTTCA and Rev- CCAGGAAATGAGCTTGACAAA. 
 
Detection of gene disruption frequency 
DNA from 1 million cells 72 hours post-transduction was isolated using the 
MasterPure complete DNA purification kit (Epicentre Biotechnologies).  Specific 
genetic loci were PCR amplified using Accuprime Supermix II (Invitrogen) and 
the corresponding primers listed in Supplemental Table 1.  PCR reactions were 
then treated with Surveyor nuclease (Integrated DNA technologies) as previously 
described,19 resolved on a 2% agarose gel, and visualized with ethidium 
bromide.  Images were captured using a UV detection camera (Canon) and band 
intensities were quantified using the ImageJ (freely available from NIH) program.   
 
 
Terminal differentiation analysis 
Cell numbers used for cellular proliferation calculations were counted using a 
standard hemocytometer.  Hemoglobin content was measured using Drabkin’s 
reagent and compared to a standard curve. 
 
Gene expression changes in erythroid differentiation by RNA-seq 
RNA sequencing expression data for Lmna and other structural proteins from 
experiments by Wong, et al.2 were accessed through Gene Expression Omnibus 
database under the accession number GSE27893. 
 
Statistics 
Standard deviations were calculated using Microsoft Excel and Graphpad Prism.  
Statistical significance between comparison groups was calculated using 
Student’s T-Test. 
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Supplemental Table S1 
 
 
Gene Guide sequence Surveyor assay forward primer Surveyor assay reverse primer 
Bcl11a TTGCTTGCGGCGAGACATGG	   CCCTGCGCCATCTTTGTATTATTTCT	   CTCAAAAGTGCACACGGTTCATG	  
Gata3 GAGCACAGCCGAGGACATGG	   GTTAAAAAGTACGTCCACCTCTTCCG	   GGGATCGCCCTCATTCTTTTCTT	  
Lcp2 CGGGACATTCTTCAAGGCCA	   GCAGAAAAGAGTCCTCTTCAACAAGG	   TGTAGCTGAGGGCCCTCC	  
Lmna TGTGACGGGGTCTCCATGGC	   CGCACGCGATCGATGTACA	   CCCTGTAGAGGAGGGCCTATTAG	  
 
 
CRISPR DNA sequences.  For all 4 genes targeted, guide sequences and primers used for the Surveyor nuclease assay 
are listed. 
Supplemental Figure S1
CCGCCCCGCAGCCCACCATGTCTCGCCGCAAGCAAGGCAAACCCCAGCA
»
Bcl11a
Lmna
GGTGGCGCGCCGCTGTGACGGGGTCTCCATGGCCGGCAGGGTGACAGT
»
CRISPR-mediated cleavage sites for Bcl11a and Lmna.  For both genes, sgRNA guide sequence is 
underlined in black.  Protospacer adjacent motif (PAM) is underlined in red.  Start codon is highlighted in
green.  Cleavage site denoted with double red arrow.
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Supplemental Figure S2 – More dynamic regulation of Lamin A than Lamin C during erythroid
dierentiation and expression loss following CRISPR-Cas9-mediated Lmna disruption.
(A) Western blot comparing Lamin A and C protein levels following transition of fetal liver erythroid progenitors
to dierentiation culture.  One million cells were loaded per lane.  
(B) Densitometry quantication of relative changes in Lamin A and C protein levels following transition of fetal
liver erythroid progenitors to dierentiation culture.  Each data point represents the mean of 3 biological
replicates with error bars denoting standard deviation. 
(C) Western blot assessing levels of Lamin A and C protein in fetal liver erythroid progenitor cells following
delivery of Cas9 with and without an sgRNA targeting Lmna.  
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Supplemental Figure S3 – CD71 and Ter119 expression during erythroid dierentiation.
(A) Representative ow cytometry plots of CD71 and Ter119 at various time points during erythroid
dierentiation culture following 3 days in erythroid maintenance culture.  
(B) Percentage of cells expressing both CD71 and Ter119 after 3 days in erythroid maintenance culture and
48 hours in erythroid dierentiation culture.  Data represent the mean of 3 biological replicates and error
bars denote standard deviation.  Dierences between the 3 conditions did not reach statistical signicance
when calculated using Student’s T-test.  Data at 24 hours was similar to 48 hours.
